Evidence map›Paper›PMID 27391223›Full record

Trial reportBMC health services research2016

Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trial.

Jeff Whittle, José-Miguel Yamal, Jeffrey D Williamson, Charles E Ford, Jeffrey L Probstfield, Barbara L Beard, Horia Marginean, Bruce P Hamilton, Pamela S Suhan, Barry R Davis and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC health services research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00000542. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000542 phase3completed

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Ran1993Registered outcomes0Posted comparisons0ConditionsCardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Heart DiseasesArmsamlodipine, chlorthalidone, diet, fat-restricted, doxazosin, Inhibitors, ACE
Open the trial in the graph
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Adherence to oral antihypertensive medications, are all medications equal?Journal of clinical hypertension (Greenwich, Conn.) · 2019
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jeff WhittleClement J Zablocki Veterans Affairs Medical Center, Milwaukee, WI, USA.
José-Miguel YamalThe University of Texas School of Public Health, Houston, TX, USA. Jose-Miguel.Yamal@uth.tmc.edu.
Jeffrey D WilliamsonWake Forest University School of Medicine, Winston-Salem, NC, USA.
Charles E FordThe University of Texas School of Public Health, Houston, TX, USA.
Jeffrey L ProbstfieldUniversity of Washington Medical Center, Seattle, WA, USA.
Barbara L BeardE.A. Conway Hospital, Monroe, LA, USA.
Horia MargineanOttawa Hospital, Ottawa, ON, Canada.
Bruce P HamiltonVeterans Affairs Medical Center, Baltimore, MD, USA.
Pamela S SuhanThe University of Toledo, Toledo, OH, USA.
Barry R DavisThe University of Texas School of Public Health, Houston, TX, USA.
ALLHAT Collaborative Research Group

Funding

CLINICAL TRIALS CENTER FOR ALLHAT-N01HC35130-268035130N01HC035130 · HC · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · 1993 to 2005
$6.3M
Visit-to-visit variability of blood pressure and CVD and renal outcomesR01HL110993 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MUNTNER, PAUL · 2012 to 2014
$1.1M
NHLBI NIH HHS HHSN268201100036CNHLBI NIH HHS N01 HC035130NHLBI NIH HHS R01 HL110993
6 · The paper itself

Abstract

backgroundPatient characteristics are associated with adherence, which has implications for planning clinical research or designing payment systems that reward superior outcomes. It is unclear to what extent clinician efforts to improve adherence can attenuate these associations.

methodsTo identify factors predicting visit and medication adherence in settings designed to optimize adherence, we did a retrospective analysis of participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT recruited participants at 632 sites in North America, Puerto Rico, and the U.S. Virgin Islands for random assignment to antihypertensive treatment with amlodipine, chlorthalidone, or lisinopril. Site investigators reported clinic characteristics at the time they applied to participate in the study and research coordinators used standardized methods to measure patient characteristics. We defined adequate visit adherence as attending at least 80 % of scheduled visits; adequate medication adherence was defined as taking 80 % or more of the randomly assigned medication at all study visits.

resultsThe 31,250 ALLHAT participants eligible for the visit adherence analysis attended 78.5 % of scheduled study visits; 68.9 % attended more than 80 % of scheduled visits. Clinic setting was predictive of both forms of adherence; adherence was worst at private clinics; clinics that enrolled more study participants had superior adherence. Adjusting for clinic characteristics and clinical factors, women, younger participants, Blacks and smokers were less likely to have adequate visit adherence. Among the 28,967 participants eligible for the medication adherence analysis, 21,261 (73.4 %) reported adequate medication adherence. In adjusted analyses, younger and less educated participants, Blacks, and smokers were less likely to report adequate adherence.

conclusionsParticipant demographics were associated with adherence despite strenuous efforts to optimize adherence. Our results could inform decisions by researchers planning trials and policymakers designing payment systems.

trial registrationNCT00000542 . Registered 27 October 1999.

Indexed as

Appointments and SchedulesDrug MonitoringPatient ComplianceAgedAmlodipineAntihypertensive AgentsBlack PeopleChlorthalidoneDemographyDouble-Blind MethodFemaleHumansHypertensionLisinoprilMaleMiddle AgedAmlodipineAntihypertensive AgentsChlorthalidoneLisinoprilAdherenceAngiotensin-converting enzyme inhibitorsCalcium channel blockersDiureticsHyperlipidemiaHypertensionRace

Identifiers

PMID27391223
PMCPMC4938977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.